Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-10, Stock:ABBV, The news for the past five days is as follows:
2019-06-03: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.
2019-06-04: NEWS1: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS2: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS3: AbbVie Presents Data from Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia.NEWS4: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS5: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS6: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.
2019-06-05: NEWS1: 101 Best Dividend Stocks to Buy for 2019 and Beyond.NEWS2: Pfizer to Launch Several Drugs Despite Generic Headwinds.NEWS3: Pfizer to Launch Several Drugs Despite Generic Headwinds.NEWS4: Pfizer to Launch Several Drugs Despite Generic Headwinds.
2019-06-06: NEWS1: Are Hedge Funds Going To Get Burned By AbbVie Inc (ABBV) ?.NEWS2: Top Ranked Income Stocks to Buy for June 6th.NEWS3: Top Ranked Income Stocks to Buy for June 6th.NEWS4: Bet on 5 Top Stocks With Rising P/E.NEWS5: Bet on 5 Top Stocks With Rising P/E.NEWS6: AbbVie Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia.NEWS7: Top Ranked Income Stocks to Buy for June 6th.NEWS8: Bet on 5 Top Stocks With Rising P/E.
2019-06-07: NEWS1: Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix.NEWS2: Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix.NEWS3: AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study.NEWS4: AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study.NEWS5: iShares Core Dividend Growth ETF Experiences Big Inflow.NEWS6: iShares Core Dividend Growth ETF Experiences Big Inflow.NEWS7: AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study.NEWS8: Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix.NEWS9: Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far.NEWS10: Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far.NEWS11: AbbVie to Present at the Goldman Sachs Global Healthcare Conference.NEWS12: Why I&apos;m Sticking With My 3 Worst-Performing Stocks of 2019 So Far.

Answer: Decrease